uniQure QURE
NASDAQ QURE
$44.50 -0.36 (-0.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

uniQure (QURE) Operating Income (2016 - 2026)

uniQure (QURE) posted quarterly Operating Income of -$52.2 million for Q2 2026, down 19.01% year-over-year from -$64.5 million in Q2 2025, and down 14.18% quarter-over-quarter from -$45.7 million in Q1 2026.

Analysis

uniQure (QURE) Operating Income (2016 - 2026) Analysis & Trends

uniQure's Operating Income history runs 11 years deep, the most recent figure standing at -$52.2 million for Q2 2026.

  • In Q2 2026, Operating Income fell 19.01% year-over-year to -$52.2 million; the TTM figure through Jun 2026 stood at -$200.1 million (down 18.21% YoY), while the FY2025 annual figure was -$185.3 million, down 0.57% from the prior year.
  • Operating Income for Q2 2026 stood at -$52.2 million, down from -$45.7 million in the prior quarter.
  • The five-year high for Operating Income was $26.5 million in Q4 2022, with the low at -$81.9 million in Q3 2023.
  • The 5-year median for Operating Income is -$51.7 million (2025), against an average of -$49.6 million.
  • The sharpest annual moves came in 2022 and 2023: Operating Income soared 1181.48% in 2022, then tumbled 333.0% in 2023.
  • uniQure's Operating Income stood at $26.5 million in 2022, then sank by 333.0% to -$61.7 million in 2023, then grew by 25.78% to -$45.8 million in 2024, then fell by 11.54% to -$51.1 million in 2025, then decreased by 2.12% to -$52.2 million in 2026.
  • Business Quant data shows QURE's Operating Income at -$52.2 million in Q2 2026, -$45.7 million in Q1 2026, and -$51.1 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 uniQure 2.95 Bn 2.95 Bn 5.49 Mn -52.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -52.20 Mn
Mar 31, 2026 -45.72 Mn
Dec 31, 2025 -51.12 Mn
Sep 30, 2025 -51.04 Mn
Jun 30, 2025 -43.87 Mn
Mar 31, 2025 -39.33 Mn
Dec 31, 2024 -45.83 Mn
Sep 30, 2024 -40.23 Mn
Jun 30, 2024 -44.01 Mn
Mar 31, 2024 -54.23 Mn
Dec 31, 2023 -61.75 Mn
Sep 30, 2023 -81.88 Mn
Jun 30, 2023 -65.07 Mn
Mar 31, 2023 -74.17 Mn
Dec 31, 2022 26.50 Mn
Sep 30, 2022 -59.52 Mn
Jun 30, 2022 -56.06 Mn
Mar 31, 2022 -54.08 Mn
Dec 31, 2021 2.07 Mn
Sep 30, 2021 -45.00 Mn